Mechanisms of apoptosis and/or necrosis have been associated with the appearance of pyknotic cells/nuclei in BC cells treated with the EGFR inhibitor erlotinib or with jolkinolide B, which targets the PI3K/AKT pathway [60,61]. This evidence concerns the gene AKT1 and breast cancer.